Drug
Mebendazole
Mebendazole: highest development phase Phase 3, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mebendazole NCT01173562 | Phase 3 | Healthy Volunteers |
Latest
No recent events.
Follow Mebendazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.